Wearable tES for Insomnia
- Disease/Condition
- Insomnia
- Drug/Device/Intervention
- PeakSleep
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Uniformed Services University of the Health Sciences
- Location
- Bethesda, United States of America
- Phase
- N/A
- Start date
- Oct 25, 2023
- End date
- Sep 01, 2025
- Enrollment
- 60 participants
Sleep Onset Latency Change from Baseline
The purpose of this study is to investigate the ability of a translational device, Teledyne
 PeakSleep, to reduce sleep onset latency, reduce time awake after sleep onset and improve
 restfulness and the subjective benefits of sleep in a patient population with insomnia via
 transcranial direct current stimulation (tDCS) applied to frontal lobe circuits.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06100185
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06100185 through Pure Global AI's free database. This phase not specified trial is sponsored by Uniformed Services University of the Health Sciences and is currently Recruiting. The study focuses on Insomnia. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.